Publications

The following includes selected recent publications from our lab.

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma

Han SJ, Reis G, Kohanbash G, Shrivastav S, Magill ST, Molinaro AM, McDermott MW, Theodosopoulos PV, Aghi MK, Berger MS, Butowski NA, Barani I, Phillips JJ, Perry A, Okada H.

J Neurooncol. 2016; 130 (3): 543-552. Epub 2016 Sep 13.

PubMed Link >

IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression

Zhang X, Rao A, Sette P, Deibert C, Pomerantz A, Kim WJ, Kohanbash G, Chang Y, Park Y, Engh J, Choi J, Chan T, Okada H, Lotze M, Grandi P, Amankulor N.

Neuro Oncol. 2016; 18 (10): 1402-12. doi: 10.1093/neuonc/now061. Epub 2016 Apr 25.

PubMed Link >

Cellular immunotherapy for malignant gliomas

Lin Y, Okada H.

Expert Opin Biol Ther. 2016; 16 (10): 1265-75. doi: 10.1080/14712598.2016.1214266. Epub 2016 Jul 29.

PubMed Link >

Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas

Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Normolle DP, Connelly AK, Dibridge S, Mason G, Whiteside TL, Okada H.

Neuro Oncol. 2016; 18 (8): 1157-68. doi: 10.1093/neuonc/now026. Epub 2016 Mar 15.

PubMed Link >